BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25550804)

  • 1. VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
    Song SH; Jeong IG; You D; Hong JH; Hong B; Song C; Jung WY; Cho YM; Ahn H; Kim CS
    Int J Clin Exp Pathol; 2014; 7(11):7681-9. PubMed ID: 25550804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
    Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
    Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in the blood serum, tumor and renal parenchyma of patients with renal cell carcinoma].
    Trapeznikova MF; Glybin PV; Tumanian VG; Gershteĭn ES; Dutov VV; Kushlinskiĭ NE
    Urologiia; 2010; (4):3-7. PubMed ID: 20973130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma.
    Klatte T; Böhm M; Nelius T; Filleur S; Reiher F; Allhoff EP
    BJU Int; 2007 Jul; 100(1):209-14. PubMed ID: 17428240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
    Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
    Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma.
    Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2006 May; 97(5):1102-8. PubMed ID: 16643499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.
    Rioux-Leclercq N; Fergelot P; Zerrouki S; Leray E; Jouan F; Bellaud P; Epstein JI; Patard JJ
    Hum Pathol; 2007 Oct; 38(10):1489-95. PubMed ID: 17597181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma.
    Sulzbacher I; Birner P; Träxler M; Marberger M; Haitel A
    Am J Clin Pathol; 2003 Jul; 120(1):107-12. PubMed ID: 12866380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
    Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
    J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of platelet derived growth factor-B and its receptor expression on the proliferation of renal cell carcinoma ACHN cells].
    Wang W; Zhang Z; Wang S; Du J; Yao X
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):170-4. PubMed ID: 25975783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G
    J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
    Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
    Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
    Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
    Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
    Schultz JD; Rotunno S; Riedel F; Anders C; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Int J Oncol; 2011 Apr; 38(4):1001-12. PubMed ID: 21249316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
    Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.